Bio-Analytical SPE Method: Empagliflozin and Sitagliptin

Estimation of Empagliflozin and Sitagliptin from human plasma samples using LC/MS-MS

Empagliflozin

Empagliflozin is an anti-diabetic medication. It works by removing excess sugar from your body through urine.

Sitagliptin

Sitagliptin is used in the treatment of type 2 diabetes mellitus. It is used along with diet and exercise to improve blood sugar control in adults with type 2 diabetes.

Dose, formulation and route of administration

10 mg/100mg tablets, Oral administration

Method Details

Drug Information

Drug Chemical Structure Molecular Weight LLOQ & ULOQ
Empagliflozin Chemical structure 450.91 g/mole 1-1000 ng/ml
Sitagliptin Chemical structure 407.31 g/mole 2-1000 ng/ml

Chromatographic Conditions

Parameters Details
Mobile phase 5 mM ammonium acetate : Acetonitrile (35:65 v/v)
Column 3 μm, HyPURITY C18 column (100 × 4.6 mm)
Flow rate 0.6 mL/min
Column temp 45°C

Mass Spectrometry Conditions

Parameters Details
Mass spec API-4000
Empagliflozin m/z 451.04 → 71.04
Empagliflozin D4 m/z 455.04 → 75.04
Sitagliptin m/z 408.1 → 235.1
Sitagliptin D4 m/z 412.1 → 239.1
Ion source ESI spray
Mode Positive ionization mode

Sample Preparation (SPE, Affinity HLB 25mg, 1 cc cartridges)

Step Procedure
Sample pretreatment Plasma + drug + IS- Add 500 uL 0.1% formic acid and shake well. Centrifuge, if needed before application on SPE
Condition 1 ml Methanol
Equilibration 1 ml Water
Sample Loading Load supernatant sample
Washing Wash-1: 1 ml water
Wash-2: 10% to 30% Methanol in water (Optimize this step for best results)
Elution 500 to 1 ml mobile phase
Direct Injection 10 uL